Dean Gregory
Vermögen: 186 459 $ am 31.07.2026
Vermögen: 186 459 $ am 31.07.2026
Dean A. Gregory is currently Director at Illinois Biotechnology Industry Organization and Independent Director at Cerus Corp.
since 2024.
Formerly, Mr. Gregory was President-Medical Devices at Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) from 2012 to 2024, Senior Vice President-Sales & Operations at Fenwal, Inc. from 2010 to 2012, and VP-Business Development, Strategy & Marketing ROW at Baxter International, Inc. from 2002 to 2007.
Education includes an MBA from DePaul University and an undergraduate degree from the University of Illinois.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CERUS CORPORATION 0,04 % | 02.06.2026 | 86.725 ( 0,04 % ) | 186 459 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CERUS CORPORATION | Direktor/Vorstandsmitglied | 01.07.2024 |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Direktor/Vorstandsmitglied | 20.01.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01.03.2024 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Geschäftsführer | 18.03.2010 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.02.2007 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen